New York State Common Retirement Fund Viracta Therapeutics, Inc. Transaction History

New York State Common Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$1.87 - $5.0 $40,382 - $107,975	-21,595 Reduced 98.13%	411 $2,000
Q4 2021 Feb 02, 2022	SELL	$3.37 - $7.91 $165 - $387	-49 Reduced 0.22%	22,006 $80,000
Q3 2021 Nov 02, 2021	SELL	$7.84 - $12.53 $70,128 - $112,080	-8,945 Reduced 28.85%	22,055 $177,000
Q2 2021 Aug 02, 2021	BUY	$7.55 - $12.95 $234,050 - $401,450	31,000 New	31,000 $352,000

9.03M

10.9K

400

Ticker VIRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,558,200
Market Cap $8.64M
Description
Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.